124 related articles for article (PubMed ID: 6235773)
1. T-lymphocyte subpopulations in Spanish haemophiliacs treated with commercial clotting factor concentrates.
Gallart T; Anegón I; Cuturi C; Acevedo G; Maragall S; Vila M; Castillo R; Triginer J; Gelabert A; Vives J
Antibiot Chemother (1971); 1983; 32():153-8. PubMed ID: 6235773
[No Abstract] [Full Text] [Related]
2. Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A.
Kessler CM; Schulof RS; Alabaster O; Goldstein AL; Naylor PH; Phillips TM; Luban NL; Kelleher JF; Reaman GH
Br J Haematol; 1984 Oct; 58(2):325-36. PubMed ID: 6236839
[TBL] [Abstract][Full Text] [Related]
3. T-lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia.
Goldsmith JC; Moseley PL; Monick M; Brady M; Hunninghake GW
Ann Intern Med; 1983 Mar; 98(3):294-6. PubMed ID: 6219601
[TBL] [Abstract][Full Text] [Related]
4. Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate.
Unzeitig JC; Church JA; Gomperts ED; Nye CA; Pasquale S; Richards W
Am J Dis Child; 1984 Jul; 138(7):645-8. PubMed ID: 6233901
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
Carr R; Veitch SE; Edmond E; Peutherer JF; Prescott RJ; Steel CM; Ludlam CA
Lancet; 1984 Jun; 1(8392):1431-4. PubMed ID: 6145879
[TBL] [Abstract][Full Text] [Related]
6. Relationships between blood product exposure and immunological abnormalities in English haemophiliacs.
Lee CA; Bofill M; Janossy G; Thomas HC; Rizza CR; Kernoff PB
Br J Haematol; 1985 May; 60(1):161-72. PubMed ID: 3890927
[TBL] [Abstract][Full Text] [Related]
7. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
[TBL] [Abstract][Full Text] [Related]
8. Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates.
Gamba G; Ippoliti G; Bajani G; Ricevuti G; Mazzone A; Badarida G; Gobbi P; Geroldi D; Ascari E
Haematologica; 1987; 72(2):129-35. PubMed ID: 3040550
[No Abstract] [Full Text] [Related]
9. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
[TBL] [Abstract][Full Text] [Related]
10. HTLV III antibodies and immunological alterations in hemophilia patients.
Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
[TBL] [Abstract][Full Text] [Related]
11. Abnormality of helper/suppressor T cell ratio in patients with hemophilia.
Yasuda K; Matsumoto K; Okubo K; Yokoyama MM; Hiyoshi Y; Natori H
J Clin Lab Immunol; 1985 Jan; 16(1):27-30. PubMed ID: 2984427
[TBL] [Abstract][Full Text] [Related]
12. Impaired cell-mediated immunity in patients with classic hemophilia.
Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
[No Abstract] [Full Text] [Related]
13. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
[No Abstract] [Full Text] [Related]
14. [Alteration of lymphocyte surface markers in patients with hemophilia].
Yasuda K; Okubo K; Sei Y; Yokoyama M; Hiyoshi Y; Oohashi K; Funatsu A; Hara A
Rinsho Ketsueki; 1984 Dec; 25(12):1928-34. PubMed ID: 6241945
[No Abstract] [Full Text] [Related]
15. HIV antibody status and immunological abnormalities in Polish haemophiliacs.
Lopaciuk S; Kacperska E; Gloskowska-Moraczewska Z; Maslanka K; Uhrynowska M; Kraj M; Seyfried H
Thromb Haemost; 1987 Feb; 57(1):41-3. PubMed ID: 3495899
[TBL] [Abstract][Full Text] [Related]
16. Some evidence for the in vivo functional activation of suppressor T cells in asymptomatic patients with hemophilia A receiving Factor VIII concentrates.
Seki H; Taga K; Nagaoki T; Barot-Ciorbaru R; Miyawaki T; Taniguchi N
Clin Immunol Immunopathol; 1985 Jan; 34(1):27-38. PubMed ID: 3155504
[TBL] [Abstract][Full Text] [Related]
17. Abnormal T-cell subpopulations in hemophilic patients receiving factor VIII concentrates from voluntary donors.
Wearne A; Joshua DE; Rickard KA; Kronenberg H
Aust N Z J Med; 1984 Apr; 14(2):149-53. PubMed ID: 6236788
[TBL] [Abstract][Full Text] [Related]
18. Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.
Brieva JA; Sequi J; Zabay JM; Pardo A; Campos A; Luz de la Sen M; Bootello A
Clin Exp Immunol; 1985 Feb; 59(2):491-8. PubMed ID: 3919981
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the lymphocyte subpopulations in haemophilia patients from Venezuela.
Merino F; Medina JW; Amesty C; De Salvo L
Blut; 1984 Oct; 49(4):359-61. PubMed ID: 6091820
[No Abstract] [Full Text] [Related]
20. A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates.
Aznar JA; Carbonell F; Jorquera JI; Carmona E; Sánchez-Cuenca JM; Trénor A; de Andrés-Medina R; González-Molina A
Ric Clin Lab; 1985; 15(4):315-21. PubMed ID: 3938863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
